This issue’s cover story delves into the latest advances in cancer genomics and how researchers are transforming cancer treatment with focused genomics.
“The work of Dr. Paolo Fortina and the staff in the Cancer Genomics Shared Facility allow the cancer center to provide the highest quality genomic analysis using Next Generation Sequencing (NGS). The technology allows us to determine the molecular drivers of an individual patient’s tumor. With NGS, we will provide more specific therapy, targeting the molecular mechanisms driving an individual patient’s tumor. In this way, we will provide the most specific and least toxic therapies for all patients who come to our door,” writes Richard G. Pestll, M.D., Ph.D., Director of the KCC, in this issue’s “Director’s Perspective.”
Look for Q&A sections on researchers and clinical staff, the latest in melanoma and breast cancer research, the phase I clinical trial program, and past and future events, including November’s Men’s Event with comedian Jay Mohr.
To read the online version of the 2012 Fall/Winter “Milestones” magazine, please visit